[Discussion on development of four diagnostic information scale for clinical re-evaluation of postmarketing herbs].

Abstract

Post-marketing re-evaluation of Chinese herbs can well reflect Chinese medicine characteristics, which is the most easily overlooked the clinical re-evaluation content. Since little attention has been paid to this, study on the clinical trial design method was lost. It is difficult to improving the effectiveness and safety of traditional Chinese medicine… (More)

Topics

Cite this paper

@article{He2011DiscussionOD, title={[Discussion on development of four diagnostic information scale for clinical re-evaluation of postmarketing herbs].}, author={Wei He and Yanming Xie and Yongyan Wang}, journal={Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica}, year={2011}, volume={36 24}, pages={3548-50} }